Azenta, Inc.(AZTA)
Life Sciences Tools & Services
Genomic Sequencing & Profiling
| Filing Date | Insider | Type | 10b5-1 | Net Shares | Ownership change | Avg. Price | Value | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-05-19 | Cornog William L Director | Purchase | +10,000 | +103.06%19,703 | $16.38 | $163,800 | View SEC filing | |
| 2025-11-25 | Cornog William L Director | Purchase | +7,000 | +37.24%25,795 | $27.13 | $189,884 | View SEC filing | |
| 2025-11-14 | Pirogova Olga SVP and CHRO | Sale | -1,085 | -5.60%18,288 | $28.54 | $30,966 | View SEC filing | |
| 2025-11-14 | Marotta John President and CEO | Purchase | +1,000 | +0.94%107,295.78 | $25.99 | $25,990 | View SEC filing | |
| 2025-11-14 | Malus Alan J Director | Purchase | +12,000 | +238.33%17,035 | $26.65 | $319,800 | View SEC filing | |
| 2025-11-14 | Zhou Ginger SVP and GM, Multiomics | Sale | -1,085 | -3.89%26,831 | $28.54 | $30,966 | View SEC filing | |
| 2025-09-12 | Marotta John President and CEO | Sale | -316 | -0.30%105,979.78 | $29.41 | $9,294 | View SEC filing | |
| 2025-08-12 | Lin Lawrence Y. EVP, CFO and Treasurer | Purchase | +2,500 | +5.75%46,013 | $27.96 | $69,900 | View SEC filing | |
| 2025-02-04 | Hughes Violetta VP, Chief Accounting Officer | Sale | -317 | -3.20%9,603 | $52.97 | $16,791 | View SEC filing | |
| 2025-02-04 | Zhou Ginger SVP and General Manager, Genom | Purchase | +417 | +1.52%27,916 | $45.88 | $19,132 | View SEC filing | |
| 2024-11-21 | Pirogova Olga SVP and CHRO | Sale | -548 | -2.75%19,373 | $40.07 | $21,958 | View SEC filing | |
| 2024-11-21 | Hughes Violetta VP, Chief Accounting Officer | Sale | -163 | -1.62%9,920 | $40.07 | $6,531 | View SEC filing | |
| 2024-11-21 | Zhou Ginger SVP and General Manager, Genom | Sale | -491 | -1.75%27,499 | $40.07 | $19,674 | View SEC filing | |
| 2024-11-21 | Wang David Dong SVP & GM, SMS | Sale | -348 | -1.42%24,114 | $40.07 | $13,944 | View SEC filing | |
| 2024-11-21 | Joseph Jason SVP, General Counsel, Secy. | Sale | -1,139 | -1.00%112,564 | $40.07 | $45,640 | View SEC filing | |
| 2024-11-21 | Cueto Herman EVP, Chief Financial Officer | Sale | -712 | -2.89%23,892 | $40.07 | $28,530 | View SEC filing | |
| 2024-11-19 | Marotta John President and CEO | Purchase | +13,966.977 | +16.07%100,861.977 | $39.59 | $552,904 | View SEC filing | |
| 2024-11-19 | HIRSCH DIDIER Director | Purchase | +1,000 | +40.57%3,465 | $39.50 | $39,500 | View SEC filing | |
| 2024-11-19 | Cornog William L Director | Purchase | +12,500 | +554.32%14,755 | $39.60 | $495,000 | View SEC filing | |
| 2024-11-19 | Madaus Martin D Director | Purchase | +4,940 | +200.41%7,405 | $40.77 | $201,404 | View SEC filing | |
| 2024-10-21 | Cueto Herman EVP, Chief Financial Officer | Sale | -1,595 | -6.09%24,604 | $43.68 | $69,670 | View SEC filing | |
| 2023-08-15 | Gray David C Chief Strategy & New Business | Sale | -21,609 | -23.43%70,610 | $56.63 | $1,223,738 | View SEC filing | |
| 2023-08-14 | Gray David C Chief Strategy & New Business | Sale | -15,188 | -16.47%77,042 | $56.37 | $856,200 | View SEC filing | |
| 2023-06-07 | MARTIN JOSEPH R Director | Sale | -2,400 | -2.74%85,175 | $43.07 | $103,368 | View SEC filing | |
| 2022-08-22 | Robertson Lindon G EVP & Chief Financial Officer | Purchase | +4,350 | +4.52%100,571 | $57.62 | $250,647 | View SEC filing |
1-25 of 289